Helve E - Search Results

1

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

Ojala JP, Helve E, Ehnholm C, Aalto-Setälä K, Kontula KK, Tikkanen MJ. Ojala JP, et al. Among authors: helve e. J Intern Med. 1991 Nov;230(5):397-405. doi: 10.1111/j.1365-2796.1991.tb00464.x. J Intern Med. 1991. PMID: 1940775 Clinical Trial.

2

Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia.

Tikkanen MJ, Ojala JP, Helve E. Tikkanen MJ, et al. Among authors: helve e. Eur J Clin Pharmacol. 1991;40 Suppl 1:S23-5. Eur J Clin Pharmacol. 1991. PMID: 2044638

3

Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.

Ojala JP, Helve E, Tikkanen MJ. Ojala JP, et al. Among authors: helve e. Cardiology. 1990;77 Suppl 4:39-49. doi: 10.1159/000174682. Cardiology. 1990. PMID: 2073671 Clinical Trial.

4

Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.

Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ. Ojala JP, et al. Among authors: helve e. Atherosclerosis. 1990 May;82(1-2):85-95. doi: 10.1016/0021-9150(90)90147-b. Atherosclerosis. 1990. PMID: 2360923

5

Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia.

Aalto-Setälä K, Gylling H, Helve E, Kovanen P, Miettinen TA, Turtola H, Kontula K. Aalto-Setälä K, et al. Among authors: helve e. Hum Genet. 1989 Jul;82(4):305-7. doi: 10.1007/BF00273986. Hum Genet. 1989. PMID: 2567693

6

Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.

Helve E, Tikkanen MJ. Helve E, et al. Atherosclerosis. 1988 Aug;72(2-3):189-97. doi: 10.1016/0021-9150(88)90080-9. Atherosclerosis. 1988. PMID: 3063268 Clinical Trial.

7

Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.

Tikkanen MJ, Helve E, Nikkilä EA. Tikkanen MJ, et al. Among authors: helve e. Eur Heart J. 1987 Aug;8 Suppl E:97-101. doi: 10.1093/eurheartj/8.suppl_e.97. Eur Heart J. 1987. PMID: 3315684 Review.

8

Use of polymerase chain reaction to detect heterozygous familial hypercholesterolemia.

Keinänen M, Ojala JP, Helve E, Aalto-Setälä K, Kontula K, Kovanen PT. Keinänen M, et al. Among authors: helve e. Clin Chem. 1990 Jun;36(6):900-3. Clin Chem. 1990. PMID: 2357830

9

Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype.

Aalto-Setälä K, Helve E, Kovanen PT, Kontula K. Aalto-Setälä K, et al. Among authors: helve e. J Clin Invest. 1989 Aug;84(2):499-505. doi: 10.1172/JCI114192. J Clin Invest. 1989. PMID: 2760198 Free PMC article.

10

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study.

Tikkanen MJ, Helve E, Jäättelä A, Kaarsalo E, Lehtonen A, Malbecq W, Oksa H, Pääkkönen P, Salmi J, Veharanta T, et al. Tikkanen MJ, et al. Among authors: helve e. Am J Cardiol. 1988 Nov 11;62(15):35J-43J. doi: 10.1016/0002-9149(88)90005-7. Am J Cardiol. 1988. PMID: 3055922 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters